Search

Displaying results 31 - 40 of 108 in total
  1. Indication

    Stage IIB Melanoma

    go.drugbank.com/conditions/DBCOND0028887
    Drugs: Pembrolizumab
  2. Indication

    High risk, early Triple Negative Breast Cancer

    go.drugbank.com/conditions/DBCOND0144329
    Drugs: Pembrolizumab
  3. Indication

    Locally advanced Unresectable Biliary Tract Cancer

    go.drugbank.com/conditions/DBCOND0162416
    Drugs: Pembrolizumab
  4. Indication

    Metastatic HER2-positive Adenocarcinoma of the Stomach

    go.drugbank.com/conditions/DBCOND0144313
    Drugs: Pembrolizumab
  5. Indication

    Metastatic Mismatch repair deficient (dMMR) solid tumors

    go.drugbank.com/conditions/DBCOND0144303
    Drugs: Pembrolizumab
  6. Indication

    Recurrent Cutaneous Squamous Cell Carcinoma

    go.drugbank.com/conditions/DBCOND0144328
    Drugs: Pembrolizumab
  7. Indication

    Refractory Classical Hodgkin's Lymphoma

    go.drugbank.com/conditions/DBCOND0144296
    Drugs: Pembrolizumab
  8. Indication

    Stage 1b Non-Small Cell Lung Cancer (NSCLC)

    go.drugbank.com/conditions/DBCOND0173418
    Drugs: Pembrolizumab
  9. Indication

    Unresectable, locally advanced HER2 negative Gastric Adenocarcinoma

    go.drugbank.com/conditions/DBCOND0162413
    Drugs: Pembrolizumab
  10. Indication

    Unresectable, locally advanced HER2-positive Adenocarcinomas of the Gastroesophageal Junction

    go.drugbank.com/conditions/DBCOND0144314
    Drugs: Pembrolizumab